Department of Commerce$3.5K obligationsEnds Dec 19, 2027
Federal contract award
1332KP21FNEEB0010
OPERATIONS AND MAINTENANCE (O&M) SUPPORT (TASK ORDER 2) UNDER THE SATELLITE OPERATIONS, MAINTENANCE, AND SUSTAINMENT (OMS) IDIQ
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Commerce |
| Office | DEPT OF COMMERCE NOAA |
| NAICS | 541519 — Other Computer Related Services |
| PSC | DA01 — Support services for activities involved with application development and support to include analysis, design, development, coding, testing, and release packaging, as well as support of off-the-shelf Business Applications. |
| Parent award / vehicle | 1332KP21DNEEB0011 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $66.1M |
| Current contract value | $67.8M |
| Potential contract value / ceiling | $67.8M |
| Start date | Mar 29, 2021 |
| Current end date | Mar 28, 2026 |
| Potential end date | Mar 28, 2026 |
| Latest award activity | Jul 14, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 32 of 32 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 14, 2026 | P26031 | $-31.9K | DEOBLIGATE UNUSED FUNDING FROM AND ADJUST NTE'S FOR CLINS 2002 AND 3002 |
| Aug 6, 2025 | P25030 | $1.6M | PROVIDE INCREMENTAL FUNDING FOR CLIN 4002 |
| Aug 4, 2025 | P25029 | $706.2K | PROVIDE INCREMENTAL FUNDING FOR CLIN 4002 |
| Jul 29, 2025 | P25028 | $-336.2K | DEOBLIGATE UNUSED FUNDS, UPDATE THE NTES FOR CLINS 0002, 1002, 2002 AND 3002, AND UPDATE FAR 52.217-8 |
| Jul 16, 2025 | P25027 | $683.8K | INCREMENTAL FUNDING FOR CLIN 4002 |
| Jul 14, 2025 | P25026 | $855.4K | INCREMENTAL FUNDING FOR CLIN 4002 |
| Jul 8, 2025 | P25025 | $317.7K | INCREMENTAL FUNDING FOR CLIN 4002 |
| Jun 24, 2025 | P25024 | $18.0K | INCREMENTAL FUNDING FOR CLIN 4002 |
| Jun 11, 2025 | P25023 | $5.9M | INCREMENTAL FUNDING FOR CLINS 4001 AND 4002 |
| May 12, 2025 | P25022 | $1.0M | INCREMENTAL FUNDING FOR CLIN 4002 |
| Mar 5, 2025 | P25021 | $0 | EXTEND PERIOD OF PERFORMANCE FOR CLIN 3002 |
| Feb 25, 2025 | P25020 | $7.6M | EXERCISE OPTION YEAR 4 |
| Feb 24, 2025 | P25019 | $0 | UPDATE ERT NAME FROM ERT INC. TO ERT LLC |
| Aug 21, 2024 | P24018 | $272.0K | INCREMENTAL FUNDING FOR CLIN 3002 |
| Aug 8, 2024 | P24017 | $0 | UPDATE THE CONTRACTING OFFICER REPRESENTATIVE TO TONISHA TRIPP |
| Jun 24, 2024 | P24016 | $52.7K | INCREMENTAL FUNDING FOR CLIN 3002 (ODCS) |
| May 16, 2024 | P24015 | $0 | EXTEND THE PERIOD OF PERFORMANCE END DATE FOR CLIN 2002 TO JUNE 30, 2024. |
| Mar 20, 2024 | P24014 | $9.6M | EXERCISE OPTION YEAR 3 |
| Mar 13, 2024 | P24013 | $0 | EXTEND THE PERIOD OF PERFORMANCE FOR CLIN 2002 TO MAY 31, 2024 |
| Feb 22, 2024 | P24012 | $0 | ADMINISTRATIVE MODIFICATION TO MAKE SEVERAL ADMINISTRATIVE CHANGES TO CORRECT ERRORS IN CONTRACT CONVERSION FROM C.AWARD |
| Aug 14, 2023 | P23011 | $882.4K | INCREMENTAL FUNDING FOR CLIN 2002 |
| Jul 3, 2023 | P23010 | $369.5K | INCREMENTAL FUNDING FOR CLIN 2002 |
| Jun 15, 2023 | P23009 | $-150.0K | DEOBLIGATE UNUSED FUNDS FROM OY1 |
| Mar 13, 2023 | P23008 | $9.5M | EXERCISE OY2 |
| Aug 9, 2022 | P22007 | $2.9M | INCREMENTAL FUNDING FOR CLIN 1002 |
| Jun 29, 2022 | P22006 | $0 | REMOVE CEILING FROM TO2 FOR TO3 |
| Jun 23, 2022 | P22005 | $100.0K | INCREMENTAL FUNDING FOR CLIN 1002 |
| Apr 19, 2022 | P22004 | $0 | ADMINISTRATIVE MOD TO UPDATE LINES OF ACCOUNTING ON CLIN 1001 |
| Mar 25, 2022 | P22003 | $10.0M | EXERCISE OPTION YEAR 1, UPDATE KEY PERSONNEL AND PWS, EXTEND CLIN 0002 ODCS |
| Aug 10, 2021 | P21002 | $3.2M | INCREMENTAL FUNDING FOR CLIN 0002 - ODCS. |
| Jul 30, 2021 | P21001 | $2.9M | INCREMENTAL FUNDING FOR CLIN 0002 - ODCS. |
| Mar 29, 2021 | 0 | $8.2M | OPERATIONS AND MAINTENANCE (O&M) SUPPORT (TASK ORDER 2) UNDER THE SATELLITE OPERATIONS, MAINTENANCE, AND SUSTAINMENT (OMS) IDIQ |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.